The use of caffeine as a respiratory stimulant in a cat.

J Vet Emerg Crit Care (San Antonio)

Foster Hospital for Small Animals, Cummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA.

Published: July 2022

Objective: To report the use of caffeine as a respiratory stimulant in a cat with hypoventilation.

Case Summary: A cat was mechanically ventilated due to persistent hypercapnia (P co  > 75 mm Hg) following median sternotomy and thymectomy. After 3 days of mechanical ventilatory support, the cat would initiate breaths but failed weaning due to persistent hypercapnia. Following administration of intravenous caffeine (total 12 mg/kg over 24 h), respiratory and mental status rapidly improved. The cat was subsequently extubated and able to maintain Pvco  < 50 mm Hg. The cat was later diagnosed with myasthenia gravis. Quality of life 13 months after discharge was reported as excellent by her owner.

New Or Unique Information Provided: Caffeine may be considered as a respiratory stimulant in cats with hypoventilation.

Download full-text PDF

Source
http://dx.doi.org/10.1111/vec.13174DOI Listing

Publication Analysis

Top Keywords

caffeine respiratory
8
respiratory stimulant
8
stimulant cat
8
persistent hypercapnia
8
cat
5
cat objective
4
objective report
4
report caffeine
4
cat hypoventilationcase
4
hypoventilationcase summary
4

Similar Publications

Introduction: Low-flow oxygen therapy (LFOT) has been the only option for infants with bronchopulmonary dysplasia (BPD) requiring supplemental oxygen after discharge for years. Nasal high-flow therapy (NHFT) has more recently become available as a home device. We compared the impact of NHFT and LFOT on respiratory morbidity and lung function over the first 4 years in infants with BPD requiring respiratory support post-discharge.

View Article and Find Full Text PDF

Background: Athletes require proper nutrition to enhance training and performance. Studies indicate that alternative sources of caffeine, such as caffeinated chewing gum, mouth rinses, energy gels, and coffee can improve performance. Therefore, this study investigated the impact of consuming caffeinated gum (CG) and repeated coffee mouth rinsing (CMR) on professional male table tennis players' aerobic capacity and explosive power.

View Article and Find Full Text PDF

Rationale: The ideal choice of initial fraction of inspired oxygen (FiO) to stabilize preterm neonates in the delivery room (DR) is not well-established.

Objective: To compare the effects of different initial FiO in neonates < 34 weeks' gestation requiring respiratory support for DR stabilization.

Methods: In this open-labeled, assessor-blinded, parallel-group randomized controlled trial, 150 neonates were allocated to initiate DR-stabilization with 60 % (n = 75) versus 30 % (n = 75) FiO, followed by titration to peripheral oxygen saturation (SpO) targets.

View Article and Find Full Text PDF

Impact of coffee intake on human aging: Epidemiology and cellular mechanisms.

Ageing Res Rev

December 2024

CNC-Center for Neuroscience and Cell Biology, Portugal; Faculty of Medicine, Portugal; MIA-Portugal, Multidisciplinary Institute of Aging, University of Coimbra, Portugal; Centro de Medicina Digital P5, Escola de Medicina da Universidade do Minho, Braga, Portugal. Electronic address:

Article Synopsis
  • Coffee has transitioned from being seen as an unhealthy habit to a beneficial lifestyle choice that can actually enhance human health.
  • Research over the past 20 years shows that moderate coffee consumption can reduce the risk of dying from major diseases, contributing to an average increase of 1.8 years in healthspan.
  • The review highlights coffee's potential positive effects on aging-related biological processes, suggesting that continued coffee intake in older adults may provide health benefits, encouraging further study into optimal consumption patterns.
View Article and Find Full Text PDF
Article Synopsis
  • The study examines how variations in adenosine and dopamine receptor genes, along with clinical factors, affect how preterm infants respond to caffeine citrate treatment for apnea of prematurity (AOP).
  • It analyzed data from 221 preterm infants, identifying 160 as responders to treatment and 61 as non-responders, while genotyping 22 genetic polymorphisms to compare outcomes.
  • Findings showed that non-responders had higher rates of complications and specific genetic variations linked to poor response, while greater gestational age was identified as a protective factor; a predictive nomogram for treatment response was also developed.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!